Members |
associationTargetComponent |
Adronat (alendronate 10 mg) uncoated tablet, 8 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Adronat (alendronate 5 mg) uncoated tablet (trade product unit of use) |
Unknown Cell Type 2 |
Adronat (alendronate 5 mg) uncoated tablet, 30 tablets (trade product pack) |
Unknown Cell Type 2 |
Adronat (alendronate 5 mg) uncoated tablet, 30 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Adronat (alendronate 5 mg) uncoated tablet, 8 tablets (trade product pack) |
Unknown Cell Type 2 |
Adronat (alendronate 5 mg) uncoated tablet, 8 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Adronat 10 mg uncoated tablet |
Unknown Cell Type 2 |
Adronat 10 mg uncoated tablet, 30 |
Unknown Cell Type 2 |
Adronat 10 mg uncoated tablet, 30, blister pack |
Unknown Cell Type 2 |
Adronat 10 mg uncoated tablet, 8 |
Unknown Cell Type 2 |
Adronat 10 mg uncoated tablet, 8, blister pack |
Unknown Cell Type 2 |
Adronat 5 mg uncoated tablet |
Unknown Cell Type 2 |
Adronat 5 mg uncoated tablet, 30 |
Unknown Cell Type 2 |
Adronat 5 mg uncoated tablet, 30, blister pack |
Unknown Cell Type 2 |
Adronat 5 mg uncoated tablet, 8 |
Unknown Cell Type 2 |
Adronat 5 mg uncoated tablet, 8, blister pack |
Unknown Cell Type 2 |
Adronat Once Weekly (alendronate 70 mg) uncoated tablet (trade product unit of use) |
Unknown Cell Type 2 |
Adronat Once Weekly (alendronate 70 mg) uncoated tablet, 1 tablet (trade product pack) |
Unknown Cell Type 2 |
Adronat Once Weekly (alendronate 70 mg) uncoated tablet, 1 tablet, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Adronat Once Weekly (alendronate 70 mg) uncoated tablet, 2 tablets (trade product pack) |
Unknown Cell Type 2 |
Adronat Once Weekly (alendronate 70 mg) uncoated tablet, 2 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Adronat Once Weekly (alendronate 70 mg) uncoated tablet, 4 tablets (trade product pack) |
Unknown Cell Type 2 |
Adronat Once Weekly (alendronate 70 mg) uncoated tablet, 4 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Adronat Once Weekly 70 mg uncoated tablet |
Unknown Cell Type 2 |
Adronat Once Weekly 70 mg uncoated tablet, 1 |
Unknown Cell Type 2 |
Adronat Once Weekly 70 mg uncoated tablet, 1, blister pack |
Unknown Cell Type 2 |
Adronat Once Weekly 70 mg uncoated tablet, 2 |
Unknown Cell Type 2 |
Adronat Once Weekly 70 mg uncoated tablet, 2, blister pack |
Unknown Cell Type 2 |
Adronat Once Weekly 70 mg uncoated tablet, 4 |
Unknown Cell Type 2 |
Adronat Once Weekly 70 mg uncoated tablet, 4, blister pack |
Unknown Cell Type 2 |
Adronat Plus 70 mg/140 microgram (alendronate 70 mg + cholecalciferol 140 microgram) uncoated tablet |
Unknown Cell Type 2 |
Adronat Plus 70 mg/140 microgram (alendronate 70 mg + cholecalciferol 140 microgram) uncoated tablet, 4 tablets |
Unknown Cell Type 2 |
Adronat Plus 70 mg/140 microgram (alendronate 70 mg + cholecalciferol 140 microgram) uncoated tablet, 4 tablets, blister pack |
Unknown Cell Type 2 |
Adronat Plus 70 mg/140 microgram (alendronate 70 mg + colecalciferol 140 microgram) uncoated tablet (trade product unit of use) |
Unknown Cell Type 2 |
Adronat Plus 70 mg/140 microgram (alendronate 70 mg + colecalciferol 140 microgram) uncoated tablet, 4 tablets (trade product pack) |
Unknown Cell Type 2 |
Adronat Plus 70 mg/140 microgram (alendronate 70 mg + colecalciferol 140 microgram) uncoated tablet, 4 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Adronat Plus 70 mg/140 microgram uncoated tablet |
Unknown Cell Type 2 |
Adronat Plus 70 mg/140 microgram uncoated tablet, 4 |
Unknown Cell Type 2 |
Adronat Plus 70 mg/140 microgram uncoated tablet, 4, blister pack |
Unknown Cell Type 2 |
Adronat Plus D-Cal (alendronate 70 mg + cholecalciferol 140 microgram) uncoated tablet [4 tablets] (&) (calcium carbonate 1.25 g) film-coated tablet [24 tablets], 1 pack |
Unknown Cell Type 2 |
Adronat Plus D-Cal (alendronate 70 mg + cholecalciferol 140 microgram) uncoated tablet [4 tablets] (&) (calcium carbonate 1.25 g) film-coated tablet [24 tablets], 1 pack |
Unknown Cell Type 2 |
Adronat Plus D-Cal (alendronate 70 mg + cholecalciferol 140 microgram) uncoated tablet [4 tablets] (&) (calcium carbonate 1.25 g) film-coated tablet [48 tablets], 1 pack |
Unknown Cell Type 2 |
Adronat Plus D-Cal (alendronate 70 mg + cholecalciferol 140 microgram) uncoated tablet [4 tablets] (&) (calcium carbonate 1.25 g) film-coated tablet [48 tablets], 1 pack |
Unknown Cell Type 2 |
Adronat Plus D-Cal (alendronate 70 mg + colecalciferol 140 microgram) uncoated tablet [4 tablets] (&) (calcium carbonate 1.25 g) film-coated tablet [24 tablets], 1 pack (containered trade product pack) |
Unknown Cell Type 2 |
Adronat Plus D-Cal (alendronate 70 mg + colecalciferol 140 microgram) uncoated tablet [4 tablets] (&) (calcium carbonate 1.25 g) film-coated tablet [24 tablets], 1 pack (trade product pack) |
Unknown Cell Type 2 |
Adronat Plus D-Cal (alendronate 70 mg + colecalciferol 140 microgram) uncoated tablet [4 tablets] (&) (calcium carbonate 1.25 g) film-coated tablet [48 tablets], 1 pack (containered trade product pack) |
Unknown Cell Type 2 |
Adronat Plus D-Cal (alendronate 70 mg + colecalciferol 140 microgram) uncoated tablet [4 tablets] (&) (calcium carbonate 1.25 g) film-coated tablet [48 tablets], 1 pack (trade product pack) |
Unknown Cell Type 2 |
Bilateral adult Kienbocks disease of lunate |
Progressive avascular necrosis of bilateral lunate bones |
Adult periodontitis |
Chronic periodontitis |
Adult rhabdomyoma |
Adult cellular rhabdomyoma |
Adult type granulosa cell tumour of testis |
Adult type granulosa cell tumour of uncertain behaviour |
Advancement of flap graft |
Reconstruction using local advancement flap |
Advantan (methylprednisolone aceponate 1 mg / 1 g) fatty ointment (trade product unit of use) |
Unknown Cell Type 2 |
Advantan (methylprednisolone aceponate 1 mg / 1 g) fatty ointment, 10 g (trade product pack) |
Unknown Cell Type 2 |
Advantan (methylprednisolone aceponate 1 mg / 1 g) fatty ointment, 10 g, tube (containered trade product pack) |
Unknown Cell Type 2 |
Advantan (methylprednisolone aceponate 1 mg / 1 g) fatty ointment, 100 g (trade product pack) |
Unknown Cell Type 2 |
Advantan (methylprednisolone aceponate 1 mg / 1 g) fatty ointment, 100 g, tube (containered trade product pack) |
Unknown Cell Type 2 |
Advantan (methylprednisolone aceponate 1 mg / 1 g) fatty ointment, 15 g (trade product pack) |
Unknown Cell Type 2 |
Advantan (methylprednisolone aceponate 1 mg / 1 g) fatty ointment, 15 g, tube (containered trade product pack) |
Unknown Cell Type 2 |
Advantan (methylprednisolone aceponate 1 mg / 1 g) fatty ointment, 30 g (trade product pack) |
Unknown Cell Type 2 |
Advantan (methylprednisolone aceponate 1 mg / 1 g) fatty ointment, 30 g, tube (containered trade product pack) |
Unknown Cell Type 2 |
Advantan (methylprednisolone aceponate 1 mg / 1 g) fatty ointment, 5 g (trade product pack) |
Unknown Cell Type 2 |
Advantan (methylprednisolone aceponate 1 mg / 1 g) fatty ointment, 5 g, tube (containered trade product pack) |
Unknown Cell Type 2 |
Advantan (methylprednisolone aceponate 1 mg / 1 g) fatty ointment, 50 g (trade product pack) |
Unknown Cell Type 2 |
Advantan (methylprednisolone aceponate 1 mg / 1 g) fatty ointment, 50 g, tube (containered trade product pack) |
Unknown Cell Type 2 |
Advantan 0.1% fatty ointment |
Unknown Cell Type 2 |
Advantan 0.1% fatty ointment, 10 g |
Unknown Cell Type 2 |
Advantan 0.1% fatty ointment, 10 g, tube |
Unknown Cell Type 2 |
Advantan 0.1% fatty ointment, 100 g |
Unknown Cell Type 2 |
Advantan 0.1% fatty ointment, 100 g, tube |
Unknown Cell Type 2 |
Advantan 0.1% fatty ointment, 15 g |
Unknown Cell Type 2 |
Advantan 0.1% fatty ointment, 15 g, tube |
Unknown Cell Type 2 |
Advantan 0.1% fatty ointment, 30 g |
Unknown Cell Type 2 |
Advantan 0.1% fatty ointment, 30 g, tube |
Unknown Cell Type 2 |
Advantan 0.1% fatty ointment, 5 g |
Unknown Cell Type 2 |
Advantan 0.1% fatty ointment, 5 g, tube |
Unknown Cell Type 2 |
Advantan 0.1% fatty ointment, 50 g |
Unknown Cell Type 2 |
Advantan 0.1% fatty ointment, 50 g, tube |
Unknown Cell Type 2 |
Advantan Fatty_foo 0.1% ointment |
Advantan Fatty 0.1% ointment |
Advantan Fatty_foo 0.1% ointment, 10 g |
Advantan Fatty 0.1% ointment, 10 g |
Advantan Fatty_foo 0.1% ointment, 10 g, tube |
Advantan Fatty 0.1% ointment, 10 g, tube |
Advantan Fatty_foo 0.1% ointment, 100 g |
Advantan Fatty 0.1% ointment, 100 g |
Advantan Fatty_foo 0.1% ointment, 100 g, tube |
Advantan Fatty 0.1% ointment, 100 g, tube |
Advantan Fatty_foo 0.1% ointment, 15 g |
Advantan Fatty 0.1% ointment, 15 g |
Advantan Fatty_foo 0.1% ointment, 15 g, tube |
Advantan Fatty 0.1% ointment, 15 g, tube |
Advantan Fatty_foo 0.1% ointment, 30 g |
Advantan Fatty 0.1% ointment, 30 g |
Advantan Fatty_foo 0.1% ointment, 30 g, tube |
Advantan Fatty 0.1% ointment, 30 g, tube |
Advantan Fatty_foo 0.1% ointment, 5 g |
Advantan Fatty 0.1% ointment, 5 g |
Advantan Fatty_foo 0.1% ointment, 5 g, tube |
Advantan Fatty 0.1% ointment, 5 g, tube |
Advantan Fatty_foo 0.1% ointment, 50 g |
Advantan Fatty 0.1% ointment, 50 g |
Advantan Fatty_foo 0.1% ointment, 50 g, tube |
Advantan Fatty 0.1% ointment, 50 g, tube |
Adverse effect of oral diphosphonate |
Bisphosphonate adverse reaction |
Adverse effects NEC |
Adverse reaction |
Adverse effects NOS |
Adverse reaction |
Adverse reaction to acidifying agent |
Adverse reaction to substance |
Adverse reaction to alkalising agents |
Adverse reaction to substance |
Adverse reaction to carbromal derivative |
Adverse reaction to carbromal |
Adverse reaction to intravenous bisphosphonate |
Bisphosphonate adverse reaction |
Adverse reaction to bromine compound |
Adverse reaction caused by bromine and/or bromine compound |
Adverse reaction to cardiac glycoside |
Adverse reaction to Digitalis glycoside |
Adverse reaction to cardiac glycosides NOS |
Adverse reaction to Digitalis glycoside |